This filing signals an insider's intent to take profits post-exercise. While the sale is not massive in absolute terms, the officer status and the recent cluster of insider sells (3 sells $621K in 30 days) warrant caution. Monitor for a follow-on Form 4 to confirm execution. The stock may face mild near-term selling pressure.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 23 $36.57entry
- T+1 · 5mo ago −1.42%α −1.38% · $36.05
- T+5 · 5mo ago −4.98%α −5.99% · $34.75
- T+20 · 4mo ago −11.92%α −13.08% · $32.21
- T+60 · 2mo ago +5.11%α +1.87% · $38.44
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Jae Kim, an officer of Septerna, filed a Form 144 to sell 94,339 shares valued at approximately $3.3 million. The sale stems from a stock option exercise, and the insider intends to sell on the open market. Given the company's size and the insider's role, this is a moderately notable signal of potential insider profit-taking.
Key Facts
- Officer Jae Kim filed a Form 144 to sell 94,339 shares of common stock.
- The proposed sale value is approximately $3.3 million based on the filing date.
- The sale is related to a stock option exercise, not a secondary market purchase.
- The filing date is June 22, 2026, and the sale is intended to occur soon.
- As a percentage of market cap, the sale is roughly 0.2% ($3.3M / $1.6B).
- Recent insider activity shows 3 sells totaling $621K in the last 30 days, making this a larger-than-average individual sale.
Financial Impact
Sale of ~$3.3 million worth of stock, approximately 0.2% of market cap. Not a controlling stake liquidation but a meaningful signal from an officer.
Risk Factors
- Potential for insider sentiment to weigh on stock near-term as profit-taking is executed.
- If additional insiders follow suit, could signal broader skepticism about valuation.
- The sale may be tax-motivated or for personal diversification, reducing its predictive value.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006351 |
| Document: 0001950047-26-006351-index.html | 0001950047-26-006351 |
| Document: 0001950047-26-006351.txt | 0001950047-26-006351 |
Track record
25 reports on SEPN
7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $41.67 −0.45% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers